BiotechTube
LTS Lohmann Therapie-Systeme

LTS Lohmann Therapie-Systeme

Andernach, Germany· Est.
ltslohmann.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

LTS Lohmann Therapie-Systeme is a leading, privately-held German CDMO focused on advanced non-invasive drug delivery technologies. With over 1,000 employees across three continents, the company leverages deep expertise in transdermal, oral, and intradermal delivery to help pharmaceutical partners overcome API challenges and bring patient-friendly products to market. Its integrated service model, from feasibility studies to commercial scale-up, positions it as a strategic partner in the growing market for alternative dosage forms aimed at improving adherence and bioavailability.

Drug Delivery

Technology Platform

Portfolio of non-invasive drug delivery platforms including Transdermal Therapeutic Systems (TTS), Oral Thin Films (OTF), dissolvable Micro Array Patches (MAP), On-Body Delivery Systems (Sorrel™), Topical Patch Systems, and Nasal Drug Delivery technologies.

Funding History

1
Total raised:$5M
Grant$5M

Opportunities

The growing demand for patient-friendly, non-invasive delivery systems for complex molecules like biologics and vaccines presents a major expansion opportunity.
The trend towards self-administration and home healthcare further drives need for LTS's easy-to-use platforms such as patches and oral films.

Risk Factors

Intense competition from other drug delivery CDMOs and technology firms risks commoditization.
Execution risk in scaling complex formulations and dependence on the success and outsourcing decisions of pharmaceutical partners are key business vulnerabilities.

Competitive Landscape

LTS competes in a crowded global CDMO and drug delivery technology market against large players like Lonza, Catalent, and 3M's Drug Delivery Systems Division, as well as specialized firms such as Vectura Group, Kindeva Drug Delivery, and Corium for transdermal and film technologies. Differentiation is achieved through its broad, integrated platform portfolio and deep expertise in formulation science.

More companies in Drug Delivery & Formulation →More companies in Germany →